Literature DB >> 171550

Envelope and nucleocapsid antigens of Cytomegalovirus (CMV).

H Schmitz, H W Doerr, M Obrig.   

Abstract

A method for the purification and concentration of Cytomegalovirus nucleocapsids and particles complete with envelope is described. Antibody to either nucleocapsid or envelope antigens can be detected in human sera. In patients with CMV disease the antibodies to the envelope antigen could not be detected before the 3rd week after the beginning of disease whereas antibodies to the nucleocapsid were detected earlier.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171550     DOI: 10.1007/bf02121005

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  17 in total

1.  THE IMMUNOFLUORESCENT FOCUS TECHNIQUE IN STUDYING THE REPLICATION OF CYTOMEGALOVIRUS.

Authors:  F RAPP; L E RASMUSSEN; M BENYESH-MELNICK
Journal:  J Immunol       Date:  1963-11       Impact factor: 5.422

2.  ULTRASTRUCTURAL, CYTOCHEMICAL, AND MICROCHEMICAL OBSERVATIONS ON CYTOMEGALOVIRUS (SALIVARY GLAND VIRUS) INFECTION OF HUMAN CELLS IN TISSUE CULTURE.

Authors:  M H MCGAVRAN; M G SMITH
Journal:  Exp Mol Pathol       Date:  1965-02       Impact factor: 3.362

3.  Electron microscope studies of cells infected with the salivary gland viruses.

Authors:  S A LUSE; M G SMITH
Journal:  Ann N Y Acad Sci       Date:  1959-07-21       Impact factor: 5.691

4.  The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2.

Authors:  C Sim; D H Watson
Journal:  J Gen Virol       Date:  1973-05       Impact factor: 3.891

5.  [Experiences with immunofluorescence determination of antibodies to cytomegalovirus].

Authors:  H Schmitz; R Haas
Journal:  Z Med Mikrobiol Immunol       Date:  1970

6.  Herpes simplex virus structural proteins.

Authors:  U Olshevsky; Y Becker
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

7.  Proteins specified by herpes simplex virus. IX. Contiguity of host and viral proteins in the plasma membrane of infected cells.

Authors:  J W Heine; B Roizman
Journal:  J Virol       Date:  1973-05       Impact factor: 5.103

8.  Human cytomegalovirus: properties of the complement-fixing antigen.

Authors:  M Benyesh-Melnick; V Vonka; F Probstmeyer; I Wimberly
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

9.  Virus specific antigens in mammalian cells infected with herpes simplex virus.

Authors:  D H Watson; W I Shedden; A Elliot; T Tetsuka; P Wildy; D Bourgaux-Ramoisy; E Gold
Journal:  Immunology       Date:  1966-10       Impact factor: 7.397

10.  [Significance of the envelope in CMV infections].

Authors:  H Schmitz
Journal:  Zentralbl Bakteriol Orig A       Date:  1974
View more
  5 in total

1.  Infectious mononucleosis and mononucleosis syndromes.

Authors:  M Fiala; D C Heiner; J A Turner; B Rosenbloom; L B Guze
Journal:  West J Med       Date:  1977-06

2.  Human cytomegalovirus infection: recent developments in diagnosis and epidemiology.

Authors:  H W Doerr; R Braun; K Munk
Journal:  Klin Wochenschr       Date:  1985-03-15

3.  Differentiation between primary and recurrent cytomegalovirus infections.

Authors:  H Schmitz; H Mohr; M Majoubi
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Distinguishing cytomegalovirus, mycoplasma, and cellular DNA polymerases.

Authors:  R L Miller; F Rapp
Journal:  J Virol       Date:  1976-12       Impact factor: 5.103

5.  Polypeptides and major antigens of four new isolates of cytomegalovirus.

Authors:  M I Siqueira-Linhares; N Faucon-Biguet; Y Chardonnet; J P Revillard
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.